Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Why did Concordia make payment to Cinven????
View:
Post by happyretirement on Feb 10, 2017 9:28am

Why did Concordia make payment to Cinven????

If as TD states that AMCo underachieved during the earn-out period....

"The company's net debt to estimated earnings before interest, taxes, depreciation

and amortization for 2016 is about 6.4 times, and it faces other challenges such as

potential drug price reforms in the U.K. Concordia's $3.5-billion (U.S.) acquisition of

Amdipharm Mercury in 2015 had been expected to become a primary driver of

growth, but the business underwhelmed for the nine months ended September, 2016".



"An earn-out payment of up to US$220 million may be payable to the sellers of AMCo

in 2016 should the AMCo group of companies achieve certain levels of gross profit

over a period of 12 months from October 1, 2015. This payment will not be made

should the AMCo group not achieve these targets".

JMO
Comment by rad10 on Feb 10, 2017 9:53am
Private equity ate Mark Thompson for breakfast.  He didnt realise when he did the AMCo deal that the improved balance sheet of the two companies merged through Cinven out of bancruptcy was purely due to gouging price hikes on second tier products and channel stuffing.  The improved AMCo balance sheet was illusory and transient - the UK government has gotten wind of it ...more  
Comment by DeathPool on Feb 10, 2017 10:07am
rad, How do you think the market will react if the exCEO is charged for his "offshore margin calls"  I think it will be the final toll  
Comment by rad10 on Feb 10, 2017 10:20am
Tough call DP - I am not a securities lawyer.  Transparency and decency can certainly be called into question but were laws broken?  I dont know the answer to that one. Reading some of the transcripts of the civil suit he brought to Cohodes - he clearly feels there was no wrong doing and that this is the "Canadian way".....................
Comment by happyretirement on Feb 10, 2017 4:46pm
He didnt realise when he did the AMCo deal that the improved balance sheet of the two companies merged through Cinven out of bancruptcy was purely due to gouging price hikes on second tier products and channel stuffing. Bankruptcy???  Are you sure?
Comment by rad10 on Feb 10, 2017 6:00pm
Close enough........... https://www.thepharmaletter.com/article/cinven-snaps-up-amdipharm-for-pound-367-million https://www.thepharmaletter.com/article/cinven-to-acquire-mercury-pharma-for-730-million enjoy!
Comment by happyretirement on Feb 10, 2017 6:13pm
Cinven's investment in AMCo is a consequence of our Healthcare sector team's identification of an opportunity to consolidate the fragmented 'off-patent' pharmaceuticals market - an attractive niche that benefits from high barriers to entry and positive demographic drivers. The Healthcare team developed a relationship with two of the most attractive and complementary ...more  
Comment by rad10 on Feb 10, 2017 6:28pm
The final payment was made to the very smart folks at Cinven who quintupled their money - the problem that was only really discovered several months after the deal was struck is now a huge issue going forward. What will be the erosion of EBIDTA and Why is no guidance being issued............ I have no issue with concordia - I have a major issue with corporate sleaze....
Comment by happyretirement on Feb 10, 2017 7:58pm
Jan 1.440257 – 31 days Feb 1.429990 – 29 days Mar 1.426061 – 31 days Apr 1.430589 – 30 days May 1.451924 – 31 days Jun 1.418438 – 30 days Jul 1.314450 – 31 days Aug 1.308817 – 31 days Sep 1.314193 – 30 days Oct 1.235094 – 31 days Nov 1.245045 – 30 days Dec 1.247756 – 31 days Jan 1.234480 – 31 days Feb 1.251520 – 11 days You think they could give ...more  
Comment by Shortingtozero2 on Feb 11, 2017 3:40am
Well happy, there are thousands of other companies with international currency exposure and they manage to give guidance!   Can you imagine if every company used this excuse to not give guidance ... that's so hilarious.
Comment by rad10 on Feb 11, 2017 10:11pm
astrazeneca and GSK are all giving guidance - big British pharma companies with massive global reach........................... Currency fluctuations are not unique to CXR. It's hardly an excuse for curtailing guidance HR........ SMH
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities